EP 1220872 A1 20020710 - UROGUANYLIN AS AN INTESTINAL CANCER INHIBITING AGENT
Title (en)
UROGUANYLIN AS AN INTESTINAL CANCER INHIBITING AGENT
Title (de)
UROGUANYLIN ALS DARMKREBSHEMMENDES MITTEL
Title (fr)
UROGUANYLINE, ANTICANCEREUX INTESTINAL
Publication
Application
Priority
- US 0021998 W 20001004
- US 15795099 P 19991006
Abstract (en)
[origin: WO0125266A1] Disclosed is a method of retarding the development of polyps and prevention, inhibition and treatment of cancer in the intestine of a subject by administration of a composition comprising a peptide with the active domain of uroguanylin, or any agonist peptide or compound binding to the guanylate cyclase receptor GC-C in the intestine.
IPC 1-7
IPC 8 full level
A61K 38/22 (2006.01); A61P 1/04 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 7/08 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 1/04 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07K 7/08 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0125266A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0125266 A1 20010412; AU 7700400 A 20010510; EP 1220872 A1 20020710; JP 2003516316 A 20030513
DOCDB simple family (application)
US 0021998 W 20001004; AU 7700400 A 20001004; EP 00966698 A 20001004; JP 2001528206 A 20001004